Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373
Study of SNX281 in Subjects With Advanced Solid Tumors and Lymphoma - Drug Trials For Money - Paid Clinical Trials

Study of SNX281 in Subjects With Advanced Solid Tumors and Lymphoma

Study of SNX281 in Subjects With Advanced Solid Tumors and Lymphoma
Conditions:   Advanced Solid Tumor;   Advanced Lymphoma
Interventions:   Drug: SNX281;   Drug: Pembrolizumab
Sponsor:   Silicon Therapeutics
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

November 14, 2020 / by / in
Comments